Jerash Reports $0.07 GAAP EPS Fiscal First Quarter, Enters PPE Market
Jerash Holdings (NASDAQ:JRSH) reported its first quarter results for fiscal 2021, ending June 30, with $18.7 million in revenue, down 17% year-over-year. The company increased sales from new global brand customers and ventured into the PPE market, with initial shipments underway. GAAP net income was $0.8 million, or $0.07 per diluted share, a decline from $1.5 million or $0.14 per diluted share in the previous year. Management anticipates 34% sequential revenue growth for the second quarter, projecting approximately $25 million in revenue.
- New customer sales increased by 15.5% from fiscal 2020.
- Entered the PPE market with initial orders and a growing pipeline.
- Cash balance of $18.5 million and working capital of $48.7 million.
- Revenue decreased 17% from $22.5 million in the prior-year quarter.
- Gross margin declined to 16.3% from 20.0% in the previous year.
- GAAP net income fell to $0.8 million from $1.5 million year-over-year.
Expands New Customer Sales; Increased Outlook for Fiscal Second Quarter
FAIRFIELD, NJ / ACCESSWIRE / August 13, 2020 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the "Company" or "Jerash"), a producer of high-quality textile goods for leading global brands, today reported results for its first quarter of fiscal year 2021, ended June 30, 2020.
First Quarter of Fiscal 2021 and Recent Highlights
- Increased sales to new global brand customers won in fiscal 2020 in both dollar value and as a percentage of sales;
- Entered the personal protective equipment (PPE) market, including shipments of initial orders to customers and a rapidly growing pipeline of orders and prospective orders;
- Received approvals to export various PPE products to Europe, the Middle East and the United States;
- Reported
$18.7 million in revenue, a decrease of17.0% from the prior-year first quarter, reflecting higher than anticipated reinstatement of customer orders during the COVID-19 pandemic; - Reported GAAP net income of
$0.8 million , or$0.07 per diluted share, compared with net income of$1.5 million , or$0.14 per diluted share in the prior-year first quarter; and - Ended the quarter with cash of
$18.5 million and working capital of$48.7 million .
Management Commentary
Sam Choi, Chairman and Chief Executive Officer, stated: "Jerash posted stronger than anticipated first quarter revenue as customers reinstated orders and prioritized production in Jordan to maximize the benefit of our duty-free status. We also shipped increased order volumes to new customers won in the past year, further diversifying our customer base and positioning Jerash for additional growth.
"We also made important progress on strategic initiatives, including entry into the high-quality face mask and PPE markets. Our new PPE subsidiary has now shipped initial orders to multiple customers and has a rapidly growing book of new orders and prospective orders from a variety of customers for export to Europe, the Middle East and North America. We are also in the process of securing clearances from the US Food and Drug Administration to further expand the products we can ship to the US and other markets. We are actively seeking acquisition candidates to bring additional scale, customer relationships and technical capabilities to Jerash, including both traditional garments and the PPE sectors. With
"For our September quarter, we expect to report sequential revenue growth and further expansion of new customer order activity. We also expect to report sequential improvement in gross margins through increased utilization of our factory capacity. We also remain vigilant in protecting our workers, with additional safety measures in place and no COVID-19 cases reported to date at our facilities."
PPE Production Update
Jerash has commenced shipments of both branded (washable) and disposable face masks to customers and is currently launching sales in additional PPE categories, including medical scrubs and surgical gowns. The Company is using both internal and partnership initiatives, including subcontract manufacturing capabilities, in order to produce PPE for certain markets, including Europe, the Middle East, and the United States.
In order to advance its PPE market development efforts, Jerash incorporated a new entity, Jerash The First Medical Supplies Manufacturing Company Limited, which has received temporary permission from Jordan's Food and Drug Administration to manufacture and export non-surgical PPE. This subsidiary has already accepted subcontracting orders of surgical masks and medical gowns for customers in Jordan, the Middle East and Europe beginning in July 2020. Jerash intends to pursue additional certifications and partnerships, including US FDA approvals, for this subsidiary and is presently engaged in these efforts.
First Quarter of Fiscal 2021 Financial Results and Second Quarter Outlook
"First quarter revenue demonstrated rapid reinstatement of orders initially suspended during the COVID-19 pandemic by our existing customers plus the addition of new orders from customers won over the past year," said Gilbert Lee, Chief Financial Officer. "Building on this momentum, we expect fiscal second quarter sales and margins to improve sequentially as factory utilization and bookings continue to increase.For the quarter ending September 30, we anticipate revenue of about
For the first quarter of fiscal 2021, Jerash reported revenue of
Gross margin for the first quarter was
Operating expenses for the first quarter of fiscal 2021 were
Operating income for the first quarter was
GAAP net income for the first fiscal quarter was
COVID-19 Update
Jerash was impacted in both the March and June quarters by business closure mandates across the country of Jordan beginning March 18. As a result of the shutdown, shipments were delayed and production at the factories halted until the government approved re-opening. Jerash's dormitory workforce was allowed to resume production within the industrial zone on April 4, but local employees were not allowed to return until June 1. Jerash enacted a number of additional screening, cleaning and monitoring programs designed to protect the health and well-being of its workforce. Jerash has been recognized as a model employer by the country of Jordan for its efforts, and no cases of COVID-19 were reported among its Jordanian employees.
Balance Sheet, Cash Flow and Dividends
Working capital increased by
Said Lee: "Cash flows improved by approximately
Jerash approved payment of a regular quarterly dividend of 5 cents per share on the Company's common stock on or about August 24, 2020, to stockholders of record on August 17, 2020.
Conference Call
The Company will conduct a conference call and webcast to review its fiscal first quarter 2021 results on Thursday, August 13, 2020, at 10:00 a.m. ET. Interested parties can access the call by dialing +1-862-298-0970. Callers should dial in at least 5 minutes prior to the call start time. A live and archived webcast will be available online in the investor relations section of Jerash's website at www.jerashholdings.com.
About Jerash Holdings (US), Inc.
Jerash Holdings (US), Inc. (NASDAQ:JRSH) is a manufacturer utilized by many well-known brands and retailers, such as Walmart, Costco, Hanes, New Balance, G-III, VF Corporation (which owns brands such as The North Face, Timberland, JanSport, etc.), and PVH Corp. (which owns brands such as Calvin Klein, Tommy Hilfiger, IZOD, etc.). Its production facilities comprise four factory units, one workshop, and three warehouses and it currently employs approximately 4,100 people. The total annual capacity at its facilities was approximately 8.0 million pieces as of June 30, 2020. Additional information is available at www.jerashholdings.com.
Forward Looking Statements
This news release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect", "seek", "potential," "outlook" and similar expressions are intended to identify forward-looking statements. Such statements reflect Jerash's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including those risks described from time to time in filings made by Jerash with the Securities and Exchange Commission. In addition, there is uncertainty about the further spread of the COVID-19 virus or the occurrence of a second wave of cases and the impact it may have on the Company's operations, the demand for the Company's products, global supply chains and economic activity in general. These and other risks and uncertainties are detailed in the Company's filings with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated or expected. Statements contained in this news release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Jerash does not intend and does not assume any obligation to update these forward-looking statements, other than as required by law.
Contact:
Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com
JERASH HOLDINGS (US), INC.,
SUBSIDIARIES AND AFFILIATE
CONDENSED CONSOLIDATED BALANCE SHEETS
June 30, 2020 | March 31, 2020 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash | $ | 17,754,673 | $ | 26,130,411 | ||||
Accounts receivable, net | 15,867,632 | 5,335,748 | ||||||
Inventories | 18,077,080 | 22,633,772 | ||||||
Prepaid expenses and other current assets | 2,239,343 | 2,761,877 | ||||||
Advance to suppliers, net | 3,168,395 | 2,116,367 | ||||||
Total Current Assets | 57,107,123 | 58,978,175 | ||||||
Restricted cash | 786,298 | 786,298 | ||||||
Long-term deposits | 329,697 | 253,414 | ||||||
Deferred tax assets, net | 139,895 | 139,895 | ||||||
Property, plant and equipment, net | 5,927,631 | 6,174,164 | ||||||
Right of use assets | 1,083,809 | 1,147,090 | ||||||
Total Assets | $ | 65,374,453 | $ | 67,479,036 | ||||
LIABILITIES AND EQUITY | ||||||||
Current Liabilities: | ||||||||
Credit facilities | $ | - | $ | 235 | ||||
Accounts payable | 3,764,543 | 6,376,320 | ||||||
Accrued expenses | 2,127,629 | 2,245,402 | ||||||
Income tax payable- current | 1,282,329 | 1,088,497 | ||||||
Other payables | 1,088,461 | 929,783 | ||||||
Operating lease liabilities - current | 187,909 | 210,081 | ||||||
Total Current Liabilities | 8,450,871 | 10,850,318 | ||||||
Operating lease liabilities - non-current | 655,598 | 649,935 | ||||||
Income tax payable - non-current | 1,227,632 | 1,227,632 | ||||||
Total Liabilities | 10,334,101 | 12,727,885 | ||||||
Commitments and Contingencies (See Note 15) | ||||||||
Equity | ||||||||
Preferred stock, | $ | - | $ | - | ||||
Common stock, | 11,325 | 11,325 | ||||||
Additional paid-in capital | 15,277,176 | 15,235,025 | ||||||
Statutory reserve | 212,739 | 212,739 | ||||||
Retained earnings | 39,244,786 | 38,997,177 | ||||||
Accumulated other comprehensive loss | (8,877 | ) | (8,324 | ) | ||||
Total Jerash Holdings (US), Inc.'s Stockholder's Equity | 54,737,149 | 54,447,942 | ||||||
Non-controlling interest | 303,203 | 303,209 | ||||||
Total Equity | 55,040,352 | 54,751,151 | ||||||
Total Liabilities and Equity | $ | 65,374,453 | $ | 67,479,036 |
JERASH HOLDINGS (US), INC.,
SUBSIDIARIES AND AFFILIATE
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(Unaudited)
For the Three Months Ended June 30, | ||||||||
2020 | 2019 | |||||||
Revenue, net | $ | 18,706,755 | $ | 22,527,325 | ||||
Cost of goods sold | 15,655,185 | 18,014,622 | ||||||
Gross Profit | 3,051,570 | 4,512,703 | ||||||
Selling, general and administrative expenses | 1,850,827 | 2,623,682 | ||||||
Stock-based compensation expenses | 42,151 | - | ||||||
Total Operating Expenses | 1,892,978 | 2,623,682 | ||||||
Income from Operations | 1,158,592 | 1,889,021 | ||||||
Other Expense: | ||||||||
Other expense, net | 2,739 | 4,533 | ||||||
Total other expense, net | 2,739 | 4,533 | ||||||
Net income before provision for income taxes | 1,155,853 | 1,884,488 | ||||||
Income tax expense | 342,000 | 335,000 | ||||||
Net Income | 813,853 | 1,549,488 | ||||||
Net loss attributable to non-controlling interest | 6 | - | ||||||
Net income attributable to Jerash Holdings (US), Inc.'s Common Stockholders | $ | 813,859 | $ | 1,549,488 | ||||
Net Income | $ | 813,853 | $ | 1,549,488 | ||||
Other Comprehensive (Loss) Income: | ||||||||
Foreign currency translation (loss) gain | (553 | ) | 811 | |||||
Total Comprehensive (Loss) Income | 813,300 | 1,550,299 | ||||||
Comprehensive loss attributable to non-controlling interest | - | - | ||||||
Comprehensive Income Attributable to Jerash Holdings (US), Inc.'s Common Stockholders | $ | 813,300 | $ | 1,550,299 | ||||
Earnings Per Share Attributable to Common Stockholders: | ||||||||
Basic | $ | 0.07 | $ | 0.14 | ||||
Diluted | $ | 0.07 | $ | 0.14 | ||||
Weighted Average Number of Shares | ||||||||
Basic | 11,325,000 | 11,325,000 | ||||||
Diluted | 11,330,210 | 11,472,363 | ||||||
Dividend per share | $ | 0.05 | $ | 0.05 |
SOURCE: Jerash Holdings
View source version on accesswire.com:
https://www.accesswire.com/601530/Jerash-Reports-007-GAAP-EPS-Fiscal-First-Quarter-Enters-PPE-Market
FAQ
What were Jerash Holdings' earnings for the first quarter of fiscal 2021?
How much revenue did Jerash Holdings generate in the first quarter of fiscal 2021?
What is Jerash Holdings' revenue outlook for the second quarter of fiscal 2021?